DJIA 15,335.28 -19.12 -0.12%
NASDAQ 3,496.43 -2.54 -0.07%
S&P 500 1,666.29 -1.18 -0.07%

Amgen, Inc.

NASDAQ: AMGN

+ Add to Portfolio

company name or ticker
Company Photos
(Click to zoom)
Working at Amgen, Inc.

Today’s 3 Worst Stocks

These three stocks embraced volatility today as investors sold off.
5/20/2013 by DailyFinance

Market Close Report: NASDAQ Composite index closes at 3,496.43 down -2.54 points

5/20/2013 by Nasdaq

Will Amgen's Novel Drug Revolutionize Cancer Treatment?

A new first-of-its-kind immunotherapy trains the immune system to target cancer cells. Can it revolutionize cancer treatment for good?
5/20/2013 by DailyFinance

China Biotech In Review: SciClone Pharma In-Licenses China Rights To Heart Failure Drug

5/19/2013 by Seeking Alpha

Here's Why Amgen Shares Are Worth $117 To $126 Today

5/18/2013 by Seeking Alpha

AGN, LLY, BIIB, CELG And AMGN, Pushing Health Care Sector Downward

5/16/2013 by TheStreet

Best And Worst ETFs, Mutual Funds And Key Holdings: All-Cap Value Style

5/16/2013 by Seeking Alpha

Sanofi and Regeneron's Latest Partnership

Late-stage clinical trials begin for this duo's experimental rheumatoid arthritis drug.
5/15/2013 by DailyFinance

Sanofi/REGN Commence Enrollment - Analyst Blog

5/15/2013 by Zacks

Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest EPS Estimates For The Next Quarte

Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest EPS Estimates For The Next Quarter
5/15/2013 by Benzinga
See More Articles...